Retatrutide 5mg

Description

Retatrutide (Triple Receptor Agonist)

Retatrutide is a highly advanced, synthetic linear polypeptide engineered to function as a tri-agonist, simultaneously targeting the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors (GCGR). In the field of molecular biology, it is specifically designed with a conjugated fatty acid moiety to study complex, simultaneous tri-receptor activation and extended molecular stability.

In-Vitro Metabolic & Receptor Cross-Talk Assays

This precision 5mg formulation serves as a premium analytical standard for investigating synergistic intracellular signaling pathways. Laboratory protocols deploy Retatrutide in isolated adipocyte and hepatic cell cultures to observe triple-receptor cross-talk, amplified cAMP accumulation, and localized lipid metabolism models independent of systemic physiological variables.

Important Research Notice: This polypeptide is manufactured strictly for in-vitro testing and academic laboratory research. For inquiries regarding specific tri-agonist assays, receptor binding affinities, or bulk analytical supplies, please contact our laboratory team.